欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
EL/H/0370/004
药品名称
ALGECIA
活性成分
pregabalin 140.0 mg
剂型
Capsule, hard
上市许可持有人
ELPEN Pharmaceutical Co. Inc. 95 Marathonos Ave., 19009, Pikermi, Athens, Greece
参考成员国 - 产品名称
Greece (GR)
互认成员国 - 产品名称
许可日期
2016/01/08
最近更新日期
2024/07/24
药物ATC编码
N03AX16 pregabalin
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final Labelling
|
Label van common_combined_v003gclean_3
Date of last change:2024/09/06
PubAR
|
PAR_NL_H_3206_001_008_DC_Algecia_05_12_2016
Date of last change:2024/09/06
Final PL
|
PIL van common_combined_v003gclean_2
Date of last change:2024/09/06
Final SPC
|
SmPC van common_combined_v003gclean
Date of last change:2024/09/06
PubAR Summary
|
summaryPAR_NL_H_3206_001_008_DC_Algecia_05_12_2016_EN
Date of last change:2024/09/06
PubAR
|
2192652_PAREN_DE 6821_Pregabalin
Date of last change:2024/09/06
Final Product Information
|
common_final_combined_6821_V009
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase